Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carboxylic PRPP, also known as CPRPP, is a synthetic carbocyclic analog of the crucial metabolic intermediate Phosphoribosyl Diphosphate (PRPP). Chemically, it is identified as [(1S,2R,3R,4R)-2,3-dihydroxy-4-(phosphonooxymethyl)cyclopentyl] phosphono hydrogen phosphate, with a molecular formula of C6H15O13P3. Unlike the natural PRPP, which features a ribose sugar ring, Carboxylic PRPP incorporates a cyclopentane ring, making it a stable, optically active carbocyclic analog. PRPP plays a central role in cellular metabolism, serving as a substrate for the biosynthesis of purine and pyrimidine nucleotides, certain amino acids (histidine and tryptophan), and cofactors like NAD and NADP. While Carboxylic PRPP is classified as a pharmaceutical chemical in databases like PubChem, its specific therapeutic indications or development status as a drug are not established; it is primarily recognized as a chemical entity for research, potentially interacting with enzymes involved in PRPP-dependent metabolic pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Carboxylic PRPP.